Navire Pharma's Seed Round

Navire Pharma raised a round of funding on October 06, 2017. Investors include BridgeBio Pharma.

Navire Pharma is developing SHP2 inhibitors as additions to the therapeutic arsenal for difficult-to-treat and rare cancers.…

Articles about Navire Pharma's Seed Round: